UG 100
LIVE

Serial Number

97386414

Owner

Ultima Genomics, Inc.

Attorney

Sheila Fox Morrison

First Use Date

May 31, 2022

Filing Date

Apr 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

UG 100 Trademark

Serial Number: 97386414 • Registration: 7950406

UG 100 is a trademark filed by Ultima Genomics, Inc. on April 28, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Ultima Genomics, Inc. (10 trademarks)

4209 Technology Drive
Fremont, CA 94538

Entity Type: 03

Trademark Details

Filing Date

April 28, 2022

Registration Date

September 16, 2025

First Use Anywhere

May 31, 2022

First Use in Commerce

February 4, 2024

Published for Opposition

June 13, 2023

Goods & Services

Apparatus and instruments for medical research and scientific research in laboratories, namely, genetic sequencers; laboratory devices for detecting genetic sequences; diagnostic apparatus for the detection of pathogens for laboratory or research use; medical research and scientific research apparatus and instruments for use in genetic analysis; apparatus for DNA and RNA testing for research purposes; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for DNA and RNA analysis; computer hardware; computer hardware for use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; data processing apparatus; scientific and research apparatus and instruments, namely, nucleic acid sequencers, arrays, scanners, electronic imaging devices and analyzers, testing sample collection equipment, sample quality control instruments, sequencing reagent cartridges and trays, and test sample preparation equipment, for laboratory use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; next-generation sequencing (NGS) bioinformatics data processor; downloadable computer software for scientific analysis of genetic sequences; embedded software sold as a component of genetic sequencing devices for scientific analysis of genetic sequences; downloadable computer software for storing, organizing, and creating a searchable library of genetic data for use in sequence detection, and disease detection and diagnosis; downloadable computer software for database management and for storage of electronic data; downloadable computer software for creating searchable databases of information and data; downloadable computer software for use in managing databases in the field of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; downloadable computer software for use in conducting medical and scientific research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; downloadable computer software for use in conducting DNA sequencing, screening, and analysis services for medical and scientific research purposes; downloadable computer software for use in conducting nucleic acid sequencing, screening, and analysis services for medical and scientific research purposes; downloadable computer software for use in conducting genomic sequencing, screening, and analysis services for medical research purposes; downloadable computer software for use in conducting genetic analysis and reporting services for medical and scientific research purposes; downloadable computer software for use in managing next-generation sequencing (NGS) bioinformatics data processor in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; downloadable computer software for compressing and decompressing genomic data files; downloadable computer software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records

Reagents, assays, enzymes, nucleotides, and buffers for medical use; diagnostic agents, reagents, preparations, and substances for medical use; kits containing reagents and a printed instructional protocol manual for use thereof for medical purposes, sold as a unit; kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, or diagnostic preparations for medical genetic testing and medical diagnostic purposes; reagents, assays, enzymes, nucleotides, buffers, and diagnostic agents and preparations for medical purposes in the fields of nucleic acid sequencing, genotyping, diagnostics, metagenomics, genetic testing, and genetics

Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical research and scientific research use; diagnostic reagents and preparations for medical research and scientific research; kits containing reagents and a protocol for use thereof for medical research and scientific purposes; agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics; kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, or biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics

Clinical or medical diagnostic apparatus and instruments, namely, nucleic acid sequencers and analyzers; medical diagnostic apparatus and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries; medical equipment, namely, devices for analyzing nucleic acids and for DNA sequencing for the purpose of rendering medical treatment and diagnosis; apparatus for DNA and RNA testing for medical purposes; medical diagnostic instruments for the analysis of body fluids; sample preparation device for medical diagnostic uses; medical diagnostic apparatus for testing DNA and RNA samples

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 16, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 25, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 25, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2025 CRFA
ASSIGNED TO LIE
Aug 7, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 16, 2025 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2024 REAP
STATEMENT OF USE PROCESSING COMPLETE
Jul 30, 2024 SUPC
USE AMENDMENT FILED
Jul 30, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 30, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 25, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 25, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 25, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 2, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 31, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 31, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 31, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 24, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 24, 2023 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 8, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 13, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 13, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 24, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 15, 2023 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 19, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2022 NWOS
NEW APPLICATION ENTERED
May 2, 2022 NWAP